Robert Chapman

1.2k total citations
17 papers, 708 citations indexed

About

Robert Chapman is a scholar working on Oncology, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Robert Chapman has authored 17 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pharmacology and 4 papers in Cognitive Neuroscience. Recurrent topics in Robert Chapman's work include Drug Transport and Resistance Mechanisms (4 papers), Liver Diseases and Immunity (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Robert Chapman is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Liver Diseases and Immunity (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Robert Chapman collaborates with scholars based in United Kingdom, United States and Spain. Robert Chapman's co-authors include Myrin Borysenko, Herbert Benson, Abdul H. Fauq, Radosveta Koldamova, Iliya Lefterov, Andrea A. Cronican, Nicholas F. Fitz, Tam N. Pham, Muzamil Saleem and G. S. Dawes and has published in prestigious journals such as The Lancet, Journal of Neuroscience and The Journal of Physiology.

In The Last Decade

Robert Chapman

17 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Chapman United Kingdom 10 200 152 130 128 92 17 708
Ifigenia Kostoglou‐Athanassiou Greece 17 167 0.8× 76 0.5× 184 1.4× 33 0.3× 68 0.7× 57 980
Shih‐Hsien Lin Taiwan 16 63 0.3× 111 0.7× 206 1.6× 73 0.6× 34 0.4× 54 769
Evangelos Bozas Greece 15 51 0.3× 164 1.1× 99 0.8× 38 0.3× 46 0.5× 31 728
H. J. Lenz United States 20 278 1.4× 237 1.6× 217 1.7× 101 0.8× 464 5.0× 66 1.3k
Pedro Leão Portugal 15 71 0.4× 225 1.5× 74 0.6× 82 0.6× 191 2.1× 52 748
Kaoru Sakamoto Japan 16 67 0.3× 149 1.0× 143 1.1× 68 0.5× 24 0.3× 79 878
Barbara Moura Antunes Brazil 20 412 2.1× 78 0.5× 127 1.0× 36 0.3× 23 0.3× 60 1.1k
I. Schweitzer Australia 19 143 0.7× 30 0.2× 60 0.5× 30 0.2× 138 1.5× 37 1.1k
Pierre F. Renault United States 9 86 0.4× 109 0.7× 44 0.3× 29 0.2× 79 0.9× 12 813
Stanley A. Blumenthal United States 14 160 0.8× 122 0.8× 135 1.0× 18 0.1× 24 0.3× 30 677

Countries citing papers authored by Robert Chapman

Since Specialization
Citations

This map shows the geographic impact of Robert Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Chapman more than expected).

Fields of papers citing papers by Robert Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Chapman. The network helps show where Robert Chapman may publish in the future.

Co-authorship network of co-authors of Robert Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Chapman. A scholar is included among the top collaborators of Robert Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Chapman. Robert Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Capitão, Liliana, Robert Chapman, Nicola Filippini, et al.. (2022). Acute neural effects of fluoxetine on emotional regulation in depressed adolescents. Psychological Medicine. 53(10). 4799–4810. 4 indexed citations
2.
Capitão, Liliana, Robert Chapman, Nicola Filippini, et al.. (2020). Neural effects of a single dose of fluoxetine on resting-state functional connectivity in adolescent depression. Journal of Psychopharmacology. 34(12). 1461–1465. 1 indexed citations
3.
Capitão, Liliana, Robert Chapman, Susannah E. Murphy, et al.. (2019). A single dose of fluoxetine reduces neural limbic responses to anger in depressed adolescents. Translational Psychiatry. 9(1). 30–30. 16 indexed citations
4.
Kowdley, K.V., Gideon M. Hirschfield, Robert Chapman, et al.. (2014). P374 LONG-TERM TREATMENT OF PRIMARY BILIARY CIRRHOSIS WITH THE FXR AGONIST OBETICHOLIC ACID SHOWS DURABLE EFFICACY. Journal of Hepatology. 60(1). S192–S193. 3 indexed citations
5.
Luketic, Velimir A., Robert Chapman, Marlyn J. Mayo, et al.. (2014). P377 THE FXR AGONIST OBETICHOLIC ACID IMPROVES A TRANSPLANT-FREE SURVIVAL-PROVEN BIOCHEMICAL RESPONSE CRITERION IN PLACEBO CONTROLLED PRIMARY BILIARY CIRRHOSIS STUDIES. Journal of Hepatology. 60(1). S193–S194. 1 indexed citations
6.
Fitz, Nicholas F., Andrea A. Cronican, Muzamil Saleem, et al.. (2012). Abca1 Deficiency Affects Alzheimer's Disease-Like Phenotype in Human ApoE4 But Not in ApoE3-Targeted Replacement Mice. Journal of Neuroscience. 32(38). 13125–13136. 106 indexed citations
7.
Hirschfield, Gideon M., K.V. Kowdley, Andrew L. Mason, et al.. (2012). 952 LONG-TERM (LT) THERAPY OF A FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) MAINTAINS BIOCHEMICAL RESPONSE IN PRIMARY BILIARY CIRRHOSIS (PBC). Journal of Hepatology. 56. S372–S372. 2 indexed citations
8.
Luketic, Velimir A., Anita Lövgren‐Sandblom, Lisbet Benthin, et al.. (2012). 964 THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) INCREASES PLASMA FGF-19 CONCENTRATIONS AND DECREASES BILE ACID SYNTHESIS IN PRIMARY BILIARY CIRRHOSIS (PBC). Journal of Hepatology. 56. S377–S377. 8 indexed citations
9.
Kowdley, Kris V., Velimir A. Luketic, Robert Chapman, et al.. (2011). 28 AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID AS MONOTHERAPY IN PBC. Journal of Hepatology. 54. S13–S13. 47 indexed citations
10.
11.
Fitz, Nicholas F., Andrea A. Cronican, Tam N. Pham, et al.. (2010). Liver X Receptor Agonist Treatment Ameliorates Amyloid Pathology and Memory Deficits Caused by High-Fat Diet in APP23 Mice. Journal of Neuroscience. 30(20). 6862–6872. 150 indexed citations
12.
Beale, John M., Robert Chapman, & John P. N. Rosazza. (1984). Studies on the biosynthesis of terrecyclic acid A, an antitumor antibiotic from Aspergillus terreus.. The Journal of Antibiotics. 37(11). 1376–1381. 9 indexed citations
13.
Borysenko, Myrin, et al.. (1983). ACADEMIC STRESS, POWER MOTIVATION, AND DECREASE IN SECRETION RATE OF SALIVARY SECRETORY IMMUNOGLOBULIN A. The Lancet. 321(8339). 1400–1402. 275 indexed citations
14.
Chapman, Robert, et al.. (1980). Breathing movements in fetal lambs and the effect of hypercapnia.. The Journal of Physiology. 302(1). 19–29. 28 indexed citations
15.
Robinson, J. S., Robert Chapman, John Challis, Murray D. Mitchell, & G. D. Thorburn. (1978). Administration of extra-amniotic arachidonic acid and the suppression of uterine prostaglandin synthesis during pregnancy in the rhesus monkey. Reproduction. 54(2). 369–373. 18 indexed citations
16.
Chapman, Robert, et al.. (1978). Intermittent breathing before death in fetal lambs. American Journal of Obstetrics and Gynecology. 131(8). 894–898. 23 indexed citations
17.
Chapman, Robert, et al.. (1973). Visceral Leishmaniasis in an English Girl. Proceedings of the Royal Society of Medicine. 66(11). 1110–1110. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026